Imtiyaz Qureshi, co-founder and director of Investeria Financial Services, says that after the recent rally in Biocon, a correction of Rs 30-40 is expected going ahead. He says investors should wait for the counter to retest Rs 514 on the downside and take long positions from there only if a bounce occurs.
